(Press-News.org) PROVIDENCE, R.I. [Brown University] — There is no specific drug to treat spinal muscular atrophy (SMA), a family of motor neuron diseases that in its most severe form is the leading genetic cause of infant death in the United States and affects one in 6,000 people overall. But a new multispecies study involving a drug that treats amyotrophic lateral sclerosis (ALS) has pinpointed a mechanism of SMA that drug developers might be able to exploit for a new therapy.
The research, published in the Journal of Neuroscience, reports that the drug Riluzole advanced neural cell development in a mammalian model of SMA and restored neuromuscular function and mobility in a Caenorhabditis elegans worm model of the disease.
Riluzole has already been tested as a therapy in a very small study of severely affected SMA patients. It failed to help. Nevertheless, what makes the new research encouraging, said Anne Hart, professor of neuroscience at Brown and senior author on the paper, is that the study traces the beneficial action of Riluzole to specific "SK2" potassium channels in worm neurons. Humans have these channels too, and if they can be more precisely targeted by a new drug, she said, that could make a more meaningful difference, at least for some patients.
"We're not suggesting based on this that SMA patients should ask their doctors for Riluzole," said Hart, who is affiliated with the Brown Institute for Brain Science, "but we are suggesting that this pathway would be useful for therapeutic development."
How Riluzole works
Because SMA has a lot in common with ALS, Hart thought Riluzole might still be worth studying in the context of SMA. To do so, she partnered with fellow researchers at Boston Children's Hospital. They worked in mouse neuronal cells while her team at Brown worked in the worms.
For each system, the researchers created SMA models in different ways by disabling the gene that produces the survival motor neuron (SMN) protein. Depletion of that protein causes SMA in people too.
In the mammalian neuronal cells, the Children's Hospital researchers found that Riluzole promoted the growth of axons that was lacking in the SMN-depleted cells. However, Riluzole did this not by increasing SMN levels. Instead, the researchers found evidence that drug treatment matured the neurons more quickly in normal cells.
Most attempts to treat SMA have relied on trying to maintain or restore higher levels of SMN, Hart noted. But Riluzole, or a future drug, may instead be able to work by accelerating cell maturity.
In the worms meanwhile, the Brown researchers found that Riluzole restored two important neuromuscular behaviors of SMA worms: the pumping action that allows the worms to move food through their digestive tracts and the body bending that they perform when swimming.
To learn how Riluzole had this effect, they performed further experiments testing various potassium channels, including SK2, that Riluzole is known to act upon. Losing these channels didn't cause more problems in animals with less SMN protein, but losing the SK2 potassium channels in particular made neuromuscular function worse. Without the SK2 channels, the drug Riluzole didn't improve function.
"This told us that Riluzole improves motorneuron function by acting through SK2 channels, which we did not know before," said lead author Maria Dimitriadi, a postdoctoral researcher in Hart's group. "This is important because understanding how SK2 channels affect motorneuron disease may eventually lead to a treatment helping both ALS and SMA patients."
###
In addition to Hart and Dimitriadi, the paper's other authors are Geetika Kalloo and Jill Yersak at Brown, and Min Jeong Kye and Mustafa Sahin at Children's Hospital and Harvard Medical School. Kye now works at the University of Cologne, Germany.
Support for the research came from the SMA Foundation, the National Institute of Neurological Diseases and Stroke (grant NS066888), the Slaney Family Fund, and Children's Hospital of Boston.
Research suggests new approach for spinal muscular atrophy
ALS drug effects highlights potassium channel role
2013-04-10
ELSE PRESS RELEASES FROM THIS DATE:
Manipulating calcium accumulation in blood vessels may provide a new way to treat heart disease
2013-04-10
Hardening of the arteries, or atherosclerosis, is the primary cause of heart disease. It is caused by calcium accumulation in the blood vessels, which leads to arteries becoming narrow and stiff, obstructing blood flow and leading to heart complications. Although many risk factors for atherosclerosis have been identified, the cause is not known and there is currently no way to reverse it once it sets in. In a new study published 9th April in the open access journal PLOS Biology, researchers have characterized the cells responsible for driving this calcium build-up in vessel ...
Bean leaves can trap bedbugs, researchers find
2013-04-10
Irvine, Calif. – Inspired by a traditional Balkan bedbug remedy, researchers have documented how microscopic hairs on kidney bean leaves effectively stab and trap the biting insects, according to findings published online today in the Journal of the Royal Society Interface. Scientists at UC Irvine and the University of Kentucky are now developing materials that mimic the geometry of the leaves.
Bedbugs have made a dramatic comeback in the U.S. in recent years, infesting everything from homes and hotels to schools, movie theaters and hospitals. Although not known to transmit ...
New gene associated with almost doubled Alzheimer's risk in African-Americans
2013-04-10
NEW YORK – African-Americans with a variant of the ABCA7 gene have almost double the risk of developing late-onset Alzheimer's disease compared with African-Americans who lack the variant. The largest genome-wide search for Alzheimer's genes in the African-American community, the study was undertaken by the Alzheimer's Disease Genetics Consortium and led by neurologists from Columbia University Medical Center. It will be published in the April 10 issue of the Journal of the American Medical Association. The study was primarily funded by the National Institutes of Health ...
Genes linked with AD among African-Americans and individuals of European ancestry
2013-04-10
In a meta-analysis of data from nearly 6,000 African Americans, Alzheimer disease was significantly associated with a gene that have been weakly associated with Alzheimer disease in individuals of European ancestry, although additional studies are needed to determine risk estimates specific for African Americans, according to a study in the April 10 issue of JAMA, a Genomics theme issue.
"Late-onset Alzheimer disease (LOAD) is the most common cause of dementia, increasing in frequency from 1 percent at age 65 years to more than 30 percent for people older than 80 years," ...
Genomics may help ID organisms in outbreaks of serious infectious disease
2013-04-10
Researchers have been able to reconstruct the genome sequence of an outbreak strain of Shiga-toxigenic Escherichia coli (STEC) using metagenomics (the direct sequencing of DNA extracted from microbiologically complex samples), according to a study in the April 10 issue of JAMA, a Genomics theme issue. The findings highlight the potential of this approach to identify and characterize bacterial pathogens directly from clinical specimens without laboratory culture.
"The outbreak of Shiga-toxigenic Escherichia coli, which struck Germany in May-June 2011, illustrated the ...
Genetic variants of heart disorder discovered in some cases of stillbirth
2013-04-10
In a molecular genetic evaluation involving 91 cases of intrauterine fetal death, mutations associated with susceptibility to long QT syndrome (LQTS; a heart disorder that increases the risk for an irregular heartbeat and other adverse events) were discovered in a small number of these cases, preliminary evidence that may provide insights into the mechanism of some intrauterine fetal deaths, according to a study in the April 10 issue of JAMA, a Genomics theme issue.
"Intrauterine fetal death is a major public health problem. About 1 million fetal deaths occur in the ...
Association between genetic mutation and risk of death for patients with thyroid cancer
2013-04-10
Presence of the genetic mutation BRAF V600E was significantly associated with increased cancer-related death among patients with papillary thyroid cancer (PTC); however, because overall mortality in PTC is low and the association was not independent of tumor characteristics, how to use this information to manage mortality risk in patients with PTC is unclear, according to a study in the April 10 issue of JAMA, a Genomics theme issue.
"Papillary thyroid cancer is the most common endocrine malignancy and accounts for 85 percent to 90 percent of all thyroid cancers," according ...
Treatment leads to near-normal life expectancy for people with HIV in South Africa
2013-04-10
In South Africa, people with HIV who start treatment with anti-AIDS drugs (antiretroviral therapy) have life expectancies around 80% of that of the general population provided that they start treatment before their CD4 count drops below 200 (cells per microliter), according to a study by South African researchers published in this week's PLOS Medicine.
These findings are encouraging and show that with long-term treatment, HIV can be managed as a chronic illness in middle- and low-income settings, and also suggest that the estimates used by life insurance companies and ...
Shingles vaccine is associated with reduction in both postherpetic neuralgia and herpes zoster
2013-04-10
Shingles vaccine is associated with reduction in both postherpetic neuralgia and herpes zoster, but uptake in the US is low
A vaccine to prevent shingles may reduce by half the occurrence of this painful skin and nerve infection in older people (aged over 65 years) and may also reduce the rate of a painful complication of shingles, post-herpetic neuralgia, but has a very low uptake (only 4%) in older adults in the United States, according to a study by UK and US researchers published in this week's PLOS Medicine.
The researchers, led by Sinéad Langan from the London ...
New guidelines for writing abstracts will help authors summarise their research
2013-04-10
New guidelines for writing abstracts will help authors summarise their research
A new extension to the PRISMA guideline on reporting systemic reviews and meta-analyses (types of studies that analyse information from many studies) will help authors to give a more robust summary (abstract) of their study and is detailed by an international group of researchers in this week's PLOS Medicine.
These guidelines for abstracts of systemic reviews and meta-analyses are important, as the abstract is the most frequently read part of most papers and these types of studies are ...
LAST 30 PRESS RELEASES:
HSE linguists study how bilinguals use phrases with numerals in Russian
Cold winters halt the northward spread of species in a warming climate
Study finds early signs of widespread coastal marsh decline
Massive burps of carbon dioxide led to oxygen-less ocean environments in the deep past
US muslims’ attitudes toward psychedelic therapy
HSE scientists reveal how staying at alma mater can affect early-career researchers
Durham University scientists reveal new cosmic insights as first Rubin Observatory images released
Emotional and directional enabled programmable flexible haptic interface for enhanced cognition in disabled community
Music on the brain: exploring how songs boost memory
Non-contact and nanometer-scale measurement of shallow PN junction depth buried in Si wafers
A unified approach to first principles calculations of Parton physics in hadrons
Killer whales groom each other using tools made from kelp
Killer whales make seaweed ‘tools’ to scratch each other’s backs
New drug for diabetes and obesity shows promising results
Role of sleep and white matter in the link between screen time and depression in childhood and early adolescence
U.S. neonatal mortality from perinatal causes
Discovery suggests new avenue for repairing brain function
Teen depression? Study finds clues in screen use and sleep quality
Alzheimer’s protective mutation works by taming inflammation in the brain
Research alert: CBD might help children with autism, but more research needed
Unveiling cutting-edge advances in CAR-T cell therapy for lymphoma
Aggressiveness responses in mice depend on the instigator
The research team led by Professor Jichuan Kang has elucidated the regulatory mechanism of AICAR biosynthesis in endophytic Fusarium solani.
Low FODMAP diet can ease GI symptoms of those with endometriosis: Study
Coupled electrons and phonons predicted to flow like water in 2D semiconductors
Repeated exposure to wildfires can incrementally increase heart failure risk
1 in 4 LGBTQ+ singles say the political climate is reshaping their dating lives
THE LANCET JOURNALS: Papers being presented at the American Diabetes Association [ADA] 85th Scientific Sessions
Research reveals why receiving food before others is a source of discomfort for social diners
Mapping the gaps: New global assessment reveals stark biases in ocean biodiversity data
[Press-News.org] Research suggests new approach for spinal muscular atrophyALS drug effects highlights potassium channel role